NM_004183.4(BEST1):c.109T>C (p.Leu37=) AND Vitelliform macular dystrophy 2
- Germline classification:
- Benign (2 submissions)
- Last evaluated:
- Jul 14, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000398665.15
Allele description [Variation Report for NM_004183.4(BEST1):c.109T>C (p.Leu37=)]
NM_004183.4(BEST1):c.109T>C (p.Leu37=)
Condition(s)
- Name:
- Vitelliform macular dystrophy 2
- Synonyms:
- VITELLIFORM MACULAR DYSTROPHY, EARLY-ONSET; VITELLIFORM MACULAR DYSTROPHY, JUVENILE-ONSET; Best disease; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0007931; MedGen: C2745945; Orphanet: 1243; OMIM: 153700
-
PREDICTED: Homo sapiens coiled-coil domain containing 78 (CCDC78), transcript va...
PREDICTED: Homo sapiens coiled-coil domain containing 78 (CCDC78), transcript variant X15, mRNAgi|2217304604|ref|XM_011522367.2|Nucleotide
-
Homo sapiens phosphatase and actin regulator 3 (PHACTR3), RefSeqGene on chromoso...
Homo sapiens phosphatase and actin regulator 3 (PHACTR3), RefSeqGene on chromosome 20gi|1543388600|ref|NG_029537.2|Nucleotide
-
transmembrane protein 41A [Rattus norvegicus]
transmembrane protein 41A [Rattus norvegicus]gi|198278547|ref|NP_001094275.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Nov 10, 2024